|
Q2 FY2026
As of Jun 30, 2026
|
Q1 FY2026
As of Mar 31, 2026
|
Q4 FY2025
As of Dec 31, 2025
|
Q3 FY2025
As of Sep 30, 2025
|
Q2 FY2025
As of Jun 30, 2025
|
Q1 FY2025
As of Mar 31, 2025
|
Q4 FY2024
As of Dec 31, 2024
|
Q3 FY2024
As of Sep 30, 2024
|
Q2 FY2024
As of Jun 30, 2024
|
Q1 FY2024
As of Mar 31, 2024
|
Q4 FY2023
As of Dec 31, 2023
|
Q3 FY2023
As of Sep 30, 2023
|
Q2 FY2023
As of Jun 30, 2023
|
Q1 FY2023
As of Mar 31, 2023
|
Q4 FY2022
As of Dec 31, 2022
|
Q3 FY2022
As of Sep 30, 2022
|
Q2 FY2022
As of Jun 30, 2022
|
Q1 FY2022
As of Mar 31, 2022
|
Q4 FY2021
As of Dec 31, 2021
|
Q3 FY2021
As of Sep 30, 2021
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||||||||||||
| Current assets: | ||||||||||||||||||||
| Cash | ||||||||||||||||||||
| Prepaid expenses and other assets | ||||||||||||||||||||
| Due from related party | ||||||||||||||||||||
| Total current assets | ||||||||||||||||||||
| Cash and marketable securities held in Trust Account | ||||||||||||||||||||
| Property and equipment, net | ||||||||||||||||||||
| Right-of-use assets - operating leases | ||||||||||||||||||||
| Deferred transaction costs | ||||||||||||||||||||
| Other assets | ||||||||||||||||||||
| Total assets | ||||||||||||||||||||
| Liabilities and stockholders’ deficit | ||||||||||||||||||||
| Current liabilities: | ||||||||||||||||||||
| Accounts payable and accrued expenses | ||||||||||||||||||||
| Accounts payable | ||||||||||||||||||||
| Accrued expenses and other liabilities | ||||||||||||||||||||
| Operating lease liabilities | ||||||||||||||||||||
| Notes payable | ||||||||||||||||||||
| Convertible promissory notes | ||||||||||||||||||||
| Loan agreement | ||||||||||||||||||||
| Due to related party | ||||||||||||||||||||
| Related Party | ||||||||||||||||||||
| Total due to related party | ||||||||||||||||||||
| Total current liabilities | ||||||||||||||||||||
| Deferred underwriting fee payable | ||||||||||||||||||||
| Convertible promissory notes | ||||||||||||||||||||
| Loan agreement | ||||||||||||||||||||
| Operating lease liabilities | ||||||||||||||||||||
| Derivative warrant liabilities | ||||||||||||||||||||
| Written call option derivative liabilities | ||||||||||||||||||||
| Total liabilities | ||||||||||||||||||||
| Class A ordinary shares subject to possible redemption, $0.0001 par value, 1,502,180 and 34,500,000 shares at redemption value of $11.10 and $10.34 per share as of December 31, 2023 and 2022, respectively | ||||||||||||||||||||
| Total class A ordinary shares subject to possible redemption, $0.0001 par value, 1,502,180 and 34,500,000 shares at redemption value of $11.10 and $10.34 per share as of December 31, 2023 and 2022, respectively | ||||||||||||||||||||
| Stockholders’ deficit | ||||||||||||||||||||
| Preferred stock, value | ||||||||||||||||||||
| Series A Preferred Stock | ||||||||||||||||||||
| Series B Preferred Stock | ||||||||||||||||||||
| Series C Preferred Stock | ||||||||||||||||||||
| Total preferred stock, value | ||||||||||||||||||||
| Class A ordinary shares; $0.0001 par value; 200,000,000 shares authorized; 13,433,333 and 1,450,000 shares issued and outstanding (excluding 2,383,053 and 34,500,000 shares subject to possible redemption) as of September 30, 2023 and December 31, 2022, respectively | ||||||||||||||||||||
| Class A ordinary shares; $0.0001 par value; 200,000,000 shares authorized; 13,433,333 and 1,450,000 shares issued and outstanding (excluding 1,502,180 and 34,500,000 shares subject to possible redemption) as of December 31, 2023 and December 31, 2022, respectively | ||||||||||||||||||||
| Common stock, $0.0001 par value; 800,000,000 shares authorized; 4,255,107 and 4,020,746 shares issued and outstanding at June 30, 2026 and December 31, 2025 | ||||||||||||||||||||
| Total common stock, $0.0001 par value; 800,000,000 shares authorized; 4,255,107 and 4,020,746 shares issued and outstanding at June 30, 2026 and December 31, 2025 | ||||||||||||||||||||
| Additional paid-in capital | ||||||||||||||||||||
| Accumulated deficit | ||||||||||||||||||||
| Total stockholders’ deficit | ||||||||||||||||||||
| Total liabilities and stockholders’ deficit | ||||||||||||||||||||
Loading...